Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-11-23 08:07:16
- Reporting Period:
- 2009-11-19
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 72444 | Nabi Biopharmaceuticals | NABI | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428524 | D. Paul Kessler | C/O Nabi Biopharmaceuticals 12276 Wilkins Ave Rockville MD 20852 | No | Yes | No | No |
Transaction Summary
| Sold: | 7,136 shares | Avg. Price: $4.90 | Total Value: $34,966.40 |
| Number of Shares After Transactions: | 88,604 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2009-11-20 | 7,136 | $4.90 | 88,604 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
